Literature DB >> 26243310

DNA repair by MGMT, but not AAG, causes a threshold in alkylation-induced colorectal carcinogenesis.

Jörg Fahrer, Janina Frisch, Georg Nagel, Alexander Kraus, Bastian Dörsam, Adam D Thomas, Sonja Reißig1, Ari Waisman1, Bernd Kaina.   

Abstract

Epidemiological studies indicate that N-nitroso compounds (NOC) are causally linked to colorectal cancer (CRC). NOC induce DNA alkylations, including O (6)-methylguanine (O (6)-MeG) and N-methylated purines, which are repaired by O (6)-MeG-DNA methyltransferase (MGMT) and N-alkyladenine-DNA glycosylase (AAG)-initiated base excision repair, respectively. In view of recent evidence of nonlinear mutagenicity for NOC-like compounds, the question arises as to the existence of threshold doses in CRC formation. Here, we set out to determine the impact of DNA repair on the dose-response of alkylation-induced CRC. DNA repair proficient (WT) and deficient (Mgmt (-/-), Aag (-/-) and Mgmt (-/-)/Aag (-/-)) mice were treated with azoxymethane (AOM) and dextran sodium sulfate to trigger CRC. Tumors were quantified by non-invasive mini-endoscopy. A non-linear increase in CRC formation was observed in WT and Aag (-/-) mice. In contrast, a linear dose-dependent increase in tumor frequency was found in Mgmt (-/-) and Mgmt (-/-)/Aag (-/-) mice. The data were corroborated by hockey stick modeling, yielding similar carcinogenic thresholds for WT and Aag (-/-) and no threshold for MGMT lacking mice. O (6)-MeG levels and depletion of MGMT correlated well with the observed dose-response in CRC formation. AOM induced dose-dependently DNA double-strand breaks in colon crypts including Lgr5-positive colon stem cells, which coincided with ATR-Chk1-p53 signaling. Intriguingly, Mgmt (-/-) mice displayed significantly enhanced levels of γ-H2AX, suggesting the usefulness of γ-H2AX as an early genotoxicity marker in the colorectum. This study demonstrates for the first time a non-linear dose-response for alkylation-induced colorectal carcinogenesis and reveals DNA repair by MGMT, but not AAG, as a key node in determining a carcinogenic threshold.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26243310     DOI: 10.1093/carcin/bgv114

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  13 in total

1.  Time-matched analysis of DNA adduct formation and early gene expression as predictive tool for renal carcinogenesis in methylazoxymethanol acetate treated Eker rats.

Authors:  Valentina Klaus; Heinke Bastek; Katja Damme; Leonard B Collins; Roland Frötschl; Norbert Benda; Dominik Lutter; Heidrun Ellinger-Ziegelbauer; James A Swenberg; Daniel R Dietrich; Kerstin Stemmer
Journal:  Arch Toxicol       Date:  2017-03-27       Impact factor: 5.153

2.  Mitochondrial DNA Integrity Is Maintained by APE1 in Carcinogen-Induced Colorectal Cancer.

Authors:  Joan Ballista-Hernández; Margaly Martínez-Ferrer; Roman Vélez; Consuelo Climent; Maria M Sánchez-Vázquez; Ceidy Torres; Adlin Rodríguez-Muñoz; Sylvette Ayala-Peña; Carlos A Torres-Ramos
Journal:  Mol Cancer Res       Date:  2017-03-30       Impact factor: 5.852

3.  Analyzing the Effects of HDAC Inhibitors on DNA Damage and Associated Cytotoxicity in Primary Hepatocytes.

Authors:  Max J Carlsson; Jörg Fahrer
Journal:  Methods Mol Biol       Date:  2023

4.  PARP-1 protects against colorectal tumor induction, but promotes inflammation-driven colorectal tumor progression.

Authors:  Bastian Dörsam; Nina Seiwert; Sebastian Foersch; Svenja Stroh; Georg Nagel; Diana Begaliew; Erika Diehl; Alexander Kraus; Maureen McKeague; Vera Minneker; Vassilis Roukos; Sonja Reißig; Ari Waisman; Markus Moehler; Anna Stier; Aswin Mangerich; Françoise Dantzer; Bernd Kaina; Jörg Fahrer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

5.  Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed mice.

Authors:  Jennifer E Kay; Joshua J Corrigan; Amanda L Armijo; Ilana S Nazari; Ishwar N Kohale; Dorothea K Torous; Svetlana L Avlasevich; Robert G Croy; Dushan N Wadduwage; Sebastian E Carrasco; Stephen D Dertinger; Forest M White; John M Essigmann; Leona D Samson; Bevin P Engelward
Journal:  Cell Rep       Date:  2021-03-16       Impact factor: 9.423

6.  DNA damage response curtails detrimental replication stress and chromosomal instability induced by the dietary carcinogen PhIP.

Authors:  Maximilian Mimmler; Simon Peter; Alexander Kraus; Svenja Stroh; Teodora Nikolova; Nina Seiwert; Solveig Hasselwander; Carina Neitzel; Jessica Haub; Bernhard H Monien; Petra Nicken; Pablo Steinberg; Jerry W Shay; Bernd Kaina; Jörg Fahrer
Journal:  Nucleic Acids Res       Date:  2016-09-05       Impact factor: 16.971

7.  Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status.

Authors:  Bartolomeus J Meijer; Mattheus C B Wielenga; Patricia B Hoyer; James M Amos-Landgraf; Theodorus B M Hakvoort; Vanesa Muncan; Jarom Heijmans; Gijs R van den Brink
Journal:  Oncotarget       Date:  2018-07-17

8.  In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi).

Authors:  Annabelle Friedrich; Ann-Sophie Assmann; Lena Schumacher; Jana V Stuijvenberg; Matthias U Kassack; Wolfgang A Schulz; Wynand P Roos; Finn K Hansen; Marc Pflieger; Thomas Kurz; Gerhard Fritz
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

9.  Biological Basis for Threshold Responses to Methylating Agents.

Authors:  Adam D Thomas
Journal:  Chem Res Toxicol       Date:  2020-05-27       Impact factor: 3.739

Review 10.  Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality.

Authors:  Pranay Ramteke; Ankita Deb; Varsha Shepal; Manoj Kumar Bhat
Journal:  Cancers (Basel)       Date:  2019-09-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.